14 commercial payer policies list 96549. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
14 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 96549 |
|---|---|---|
| Antineoplaston Cancer Therapy | Jan 1, 2026 | Covered |
| Hyperthermic Intraperitoneal Chemotherapy for Select Intra- Abdominal and Pelvic Malignancies | Oct 1, 2026 | Covered |
| Insulin Potentiation Therapy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 96549 |
|---|---|---|
| Antineoplaston Cancer Therapy | Jan 1, 2026 | Covered |
| Hyperthermic Intraperitoneal Chemotherapy for Select Intra- Abdominal and Pelvic Malignancies |
| Oct 1, 2026 |
| Covered |
| Insulin Potentiation Therapy | Jun 15, 2026 | Covered |
|---|
| Policy | Effective | Status of 96549 |
|---|---|---|
| Antineoplaston Cancer Therapy | Jan 1, 2026 | Covered |
| Hyperthermic Intraperitoneal Chemotherapy for Select Intra- Abdominal and Pelvic Malignancies | Oct 1, 2026 | Covered |
| Insulin Potentiation Therapy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 96549 |
|---|---|---|
| Antineoplaston Cancer Therapy | Jan 1, 2026 | Covered |
| Hyperthermic Intraperitoneal Chemotherapy for Select Intra- Abdominal and Pelvic Malignancies | Oct 1, 2026 | Covered |
| Insulin Potentiation Therapy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 96549 |
|---|---|---|
| Hematopoietic Cell Transplantation for Testicular Cancer | Sep 11, 2023 | Covered |
| Policy | Effective | Status of 96549 |
|---|---|---|
| Complementary and Alternative Medicine | Feb 15, 2026 | Not covered |